The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...

DR was graded according to early Treatment Diabetic Retinopathy (ETDRS ... (70.35%), which included 34 patients (17.1%) with mild non proliferative DR (NPDR), 34 patients (17.1%) with moderate ...

jsiec.org Purpose To determine the prevalence and risk factors for diabetic retinopathy (DR) and sight-threatening ... STDR was defined as the presence of preproliferative DR (R2), proliferative DR ...

James analyst Dane Leone maintained a Strong Buy rating and a $19.00 price target on Ocular Therapeutix (NASDAQ:OCUL), aligning with the broader analyst consensus. According to InvestingPro data, ...

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

Nathan Congdon, MD, highlights a recent study showing how virtual mentor-mentee relationships through Orbis' free ...